By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Perrigo Company 

515 Eastern Avenue

Allegan  Michigan  49010  U.S.A.
Phone: 616-673-8451 Fax: 616-673-9128



Company News
Mylan (MYL) Notifies Perrigo Company (PRGO) Of HSR Filing Regarding Proposed Acquisition 4/13/2015 6:33:09 AM
Mylan (MYL) Offers $30 Billion Bid for Irish Perrigo Company (PRGO), As Share Price Skyrockets 4/8/2015 10:40:43 AM
Perrigo Company (PRGO) Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 3/30/2015 12:00:22 PM
Perrigo Company (PRGO) To Present At The 2015 Barclays Global Healthcare Conference 3/4/2015 10:33:21 AM
Perrigo Company (PRGO) To Present At The 33rd Annual J.P. Morgan Healthcare Conference 1/6/2015 1:57:50 PM
Perrigo Company (PRGO) Announces FDA Approval And Launch Of The Generic Version Of Pennsaid 1.5% W/W 12/2/2014 10:29:58 AM
Perrigo Company (PRGO) Confirms First To File Patent Challenge For Generic Version Of Aveed (Testosterone Undecanoate) Injection 11/24/2014 10:06:08 AM
Perrigo Company (PRGO) Announces The Launch Of A Generic Version Of Astellas' Protopic Ointment 0.1% And 0.03% 11/24/2014 9:50:03 AM
Perrigo Company plc Announces Proposed Public Offering Of Senior Notes Of Its Finance Subsidiary, Perrigo Finance plc 11/24/2014 9:48:53 AM
Perrigo Company (PRGO) Announces Expiration Of Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023, 5.30% Senior Notes Due 2043 10/2/2014 8:33:33 AM